<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UCL_blah2 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UCL/blah2</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><NAV class="mainmenu"><DIV id="menu" class="menu"><DIV class="menu-items"><DIV id="igemlogo"><UL style="margin-top:-5px;"><UL style="margin-left:-50px;"><DIV id="ucligemlogo"><UL style="margin-top:5px;"><UL style="margin-left:-50px;"><UL style="margin-left:150px;"><LI><A href="https://2015.igem.org/Team:UCL/Description">Project</A></LI><LI><A href="#">Lab work</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Effectors">Psychobiotics</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Sensors">Mood Detection</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Safety">Built-in Biosafety</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Design">Gut-on-Chip</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Interlabstudy">InterLab Study</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Protocols">Protocols</A></LI></UL><LI><A href="#">Practices</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Practices">Integrated Human Practices</A></LI><LI><A href="https://2015.igem.org/Team:UCL/PublicEngagement">Education and Public Engagement</A></LI></UL><LI><A href="https://2015.igem.org/Team:UCL/">Outcomes</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Achievements">Medal Criteria</A></LI></UL><LI><A href="https://2015.igem.org/Team:UCL/Notebook">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Entrepreneurship">ProKao</A></LI><LI><A href="https://2015.igem.org/Team:UCL/People">People</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Advisors">Advisors</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Sponsors">Sponsors</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Attributions">Attributions</A></LI></DIV></UL></UL></DIV></DIV></DIV></NAV><DIV id="hidden-menu"><UL id="mobile-list"><LI><A href="https://2015.igem.org/Team:UCL">Home</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Experiments">Labwork</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:UCL/Notebook">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:UCL/People">People</A></LI><LI><A href="https://2015.igem.org/Team:UCL/PolicyandPractice">Policy &amp; Practice</A></LI></UL></DIV></DIV><DIV id="header2"><DIV id="wrapper"><DIV id="submenu"><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Background</A><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Our constructs</A><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Modelling</A><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Cloning</A><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Characterization</A><A data-scroll="" data-options="{ &quot;easing&quot;: &quot;linear&quot; }" href="#intro1" class="buttonblack">Summary</A></DIV><DIV id="text"><H2> Background </H2><H4> The term <B>psychobiotics</B> describes an emerging class of mind-altering probiotics that possess the ability to produce neuroactive compounds. The molecules associated with <B>mammalian neurotransmission</B> that have been isolated from gut bacteria include <B>gamma-butyric acid (GABA)</B>, <B>serotonin</B>, <B>dopamine</B>, and <B>acetylcholine</B> [1]. When secreted into intestinal lumen, these molecules can modulate the neural signalling within the enteric nervous system which communicates with brain via the vagus nerve, therefore <B>influencing brain’s biochemistry and host’s behaviour</B>. <P><I>
“It is well recognized that some bacteria within the human GIT have the capacity
to produce many neurotransmitters and neuromodulators. For example, Lactoba
cillus spp. and Bifidobacterium spp. have been reported to produce GABA;
Escherichia spp., and Bacillus spp. have been reported to produce norepinephrine;
Streptococcus spp., Escherichia spp. and Enterococcus spp. have been reported to
produce serotonin; Bacillus spp. have been reported to produce dopamine, and
Lactobacillus spp. have been reported to produce acetylcholine and histamine. [...] Other bacterially-produced metabolites with proven neuroactive func-
tions include short chain fatty acids (SCFAs) and long chain fatty acids such as
conjugated linoleic acid (CLA). “ </I><SPAN style="font-size: 10px;">
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
Advances in Experimental Medicine and Biology Volume 817, 2014, pp 221-239</SPAN></P></H4><H2> Our constructs </H2><H2>Modelling</H2><H2>Cloning</H2></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>